Creator: Stride
Published: 2026-06-08T00:00:00.000Z

Semaglutide is the active ingredient behind two of the most-discussed weight-loss drugs in the world today — Ozempic and Wegovy. It's also available as Rybelsus, an oral tablet. Same molecule, three brand names, three different doses and indications. This guide explains what semaglutide actually is, how it works in the body, what to expect when you take it, what it costs in India, and how to access it legally.

What semaglutide is

Semaglutide is a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) is a gut hormone your body releases after meals. It does three things:

Signals satiety to the brain — the "I'm full" sensation
Slows gastric emptying — food sits longer in your stomach, you feel fuller for longer
Stimulates insulin release when blood sugar is elevated, and suppresses glucagon — which is why GLP-1 drugs were first developed for type 2 diabetes

Semaglutide mimics natural GLP-1 but has been chemically modified to last about a week in the body, so you only need one dose per week (or one tablet per day, for Rybelsus).

Where semaglutide is in your weight loss

In the STEP-1 trial, adults with obesity who took Wegovy (semaglutide 2.4 mg) lost an average of 14.9% of body weight over 68 weeks, compared to 2.4% on placebo. That magnitude of medical weight loss was previously only achievable with bariatric surgery.

Translated: a 90 kg adult could expect to lose roughly 13 kg over 14 months on Wegovy, with appropriate diet and movement support.

Lower doses (Ozempic 1 – 2 mg, Rybelsus 7 – 14 mg) produce less weight loss but still meaningful improvements for patients with type 2 diabetes.

Semaglutide forms in India

Form	Brand	Dose	Approved for
Weekly injection	Ozempic	0.25 – 2 mg	Type 2 diabetes
Weekly injection	Wegovy	2.4 mg	Chronic weight management
Daily oral tablet	Rybelsus	3, 7, 14 mg	Type 2 diabetes

All three are prescription-only in India. Wegovy and Ozempic require refrigeration (cold chain); Rybelsus is shelf-stable.

How to take it

Wegovy / Ozempic (injection):

Once weekly, same day each week, at any time of day
Self-administered subcutaneously (abdomen, thigh, upper arm)
Pre-filled pen — your doctor demonstrates technique on the first prescription
Rotate injection sites to avoid skin irritation

Rybelsus (tablet):

Once daily, on an empty stomach, first thing in the morning
With no more than 4 oz (≈120 ml) of plain water
Wait at least 30 minutes before eating, drinking, or other oral medications
The narrow ingestion window matters — Rybelsus absorption is poor if taken with food

What to expect month by month

Phase	What's happening
Weeks 1 – 4 (0.25 mg)	Mild nausea after meals as your gut adjusts. Reduced appetite. Often 1 – 2 kg weight loss.
Weeks 5 – 12 (titrating up)	Side effects usually peak around dose increases and settle in 5 – 7 days. Steady weight loss begins.
Months 3 – 6 (maintenance)	Side effects largely settled. Average 5 – 10% body weight loss by month 6.
Months 6 – 12	Continued slower loss. Total ≈ 14 – 17% on Wegovy maintenance dose with lifestyle support.
Beyond 12 months	Plateau and maintenance phase. Long-term continuation decision discussed with your doctor.

The pattern is slow and steady, not dramatic. People who expect 10 kg in the first month are usually disappointed; people who plan for a year-long medical process do better.

Side effects: what's real and what to do

Common (≥10%) — usually settle in 4 – 8 weeks:

Nausea (~44% on Wegovy, less on lower doses)
Constipation
Diarrhoea
Mild reflux
Headache and fatigue early on
Reduced appetite (intended)

Management strategies your doctor will discuss:

Eat slowly, stop when satisfied (not full)
Smaller meals, more often
Higher protein, lower fat in the first weeks
Hydration — 2 – 2.5 L daily
Avoid alcohol and spicy/oily food during titration weeks
Anti-nausea medication if needed (your doctor decides)

Rare but serious — call your doctor immediately if you experience:

Severe, persistent abdominal pain (possible pancreatitis)
Persistent vomiting
Right-upper-quadrant pain (possible gallbladder issue)
Signs of allergic reaction (rash, breathing difficulty, swelling)
A lump in the neck or persistent hoarseness (rare thyroid concern)

Who can't take semaglutide

Semaglutide is not appropriate if you have:

Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
History of severe pancreatitis
Severe gastrointestinal disease (e.g., gastroparesis)
Currently pregnant, breastfeeding, or planning pregnancy in the next 2 months
Type 1 diabetes (off-label use only)

Your doctor's job is to rule these out before prescribing.

Semaglutide price in India (current, May 2026)

Approximate ranges after the major shifts of late 2025 / early 2026:

Form	Monthly cost
Ozempic 0.5 mg	₹10,000 – ₹13,000
Ozempic 1 mg	₹12,000 – ₹16,000
Ozempic 2 mg	₹15,000 – ₹18,000
Wegovy 1.7 mg (post Nov 2025 cut)	₹14,200 – ₹15,500
Wegovy 2.4 mg (post Nov 2025 cut)	₹15,500 – ₹16,400
Generic Indian semaglutide (post March 2026 patent expiry)	₹3,000 – ₹6,000
Rybelsus 14 mg	₹9,000 – ₹13,000

Two recent shifts:

Novo Nordisk cut Wegovy's price by 37% in November 2025 — bringing maintenance dose to ₹15,500 – ₹16,400 (down from a launch price of ₹26,000+).
Semaglutide's Indian patent expired March 20, 2026 — at least 5 Indian manufacturers (Cipla, Sun Pharma, Dr Reddy's, Lupin, Biocon and others) launched semaglutide generics at fractions of branded pricing.

These are the drug-only costs. Add consultation, blood work, and follow-up monitoring for the actual cost of doing this safely.

How to access semaglutide legally in India

Get a medical assessment — BMI, history, current medications, conditions.
Get appropriate blood work — fasting glucose, HbA1c, lipid panel, kidney + liver function, TSH.
Consult a registered Indian medical practitioner — in person or via telemedicine (Telemedicine Practice Guidelines, 2020).
Receive a written prescription — required by law for purchase.
Purchase from a licensed pharmacy that maintains cold-chain for injections.
Continuous follow-up — dose titration, side-effect management, lab monitoring.

Skipping any of these steps is unsafe and illegal in India.

How Stride structures this

Stride bundles every step of the semaglutide pathway into one 3-month program:

Online assessment
At-home blood test, scheduled at your convenience
Doctor video consultation
Monthly medication delivery (when clinically appropriate)
Personalized nutrition support
Ongoing care-team check-ins

3-Month Early Edition: ₹9,999 (regular ₹23,999). One-time payment.

Frequently asked questions

Is semaglutide legal in India? Yes — Ozempic, Wegovy, and Rybelsus are all approved in India. They are prescription-only.

Can I take semaglutide for weight loss without diabetes? Yes — Wegovy is specifically indicated for chronic weight management in adults with BMI ≥ 30, or ≥ 27 with comorbidities. Diabetes is not a requirement.

Is the oral version (Rybelsus) as effective for weight loss? Rybelsus produces less weight loss than Wegovy because the maximum dose (14 mg/day) is lower than what's used in Wegovy (2.4 mg/week, with much higher bioavailability). It's an option for patients who can't or won't inject.

Do I take it forever? Stopping abruptly typically leads to weight regain. Most patients use semaglutide long-term, much like medications for hypertension. Duration is a shared decision with your doctor.

How long until I see results? Most patients notice reduced appetite in the first 2 weeks. Visible weight loss usually begins by week 4 – 8. Most weight loss happens in months 3 – 12.

Will my insurance cover it? Most Indian retail health policies don't cover obesity medications. Some corporate or premium policies cover semaglutide when prescribed for diabetes. Check your policy.

Can I drink alcohol on semaglutide? Light, occasional alcohol is generally tolerated once side effects have settled. Heavy alcohol use is discouraged — it worsens nausea, raises pancreatitis risk, and undermines weight loss outcomes.